Thermo Fisher Scientific (TMO)

EBITDA

$11.57B

TTM · Period ending: · USD

TMO logo

TMO EBITDA

Latest reported$11.57B
TMO TTM EBITDA ($12.40M → $11.57B)
High-resolution chart · PNG

TMO ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Thermo Fisher Scientific EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
11,570,000,000
11,464,000,000
11,476,000,000
11,328,000,000
11,400,000,000
11,579,000,000
11,738,000,000
11,693,000,000
11,798,000,000
11,432,000,000
11,167,000,000
11,038,000,000
10,639,000,000
10,929,000,000
11,942,000,000
11,754,000,000
12,071,000,000
11,999,000,000
11,963,000,000
12,899,000,000
12,941,000,000
12,076,000,000
10,105,000,000
8,219,000,000
6,809,000,000
6,990,000,000
7,023,000,000
7,009,000,000
6,983,000,000
6,385,000,000
6,196,000,000
6,013,500,000
5,632,500,000
5,322,500,000
5,053,300,000
4,750,800,000
4,571,000,000
4,463,300,000
4,380,200,000
4,233,400,000
4,255,600,000
4,152,500,000
4,039,500,000
4,011,300,000
4,022,300,000
4,010,900,000
3,973,400,000
3,587,300,000
3,258,800,000
2,837,600,000
2,626,700,000
2,594,900,000
2,517,900,000
2,541,700,000
2,494,700,000
2,443,900,000
2,386,700,000
2,263,900,000
2,163,700,000
2,078,600,000
2,022,700,000
1,998,300,000
1,962,800,000
1,951,800,000
1,934,600,000
1,920,400,000
1,832,500,000
1,852,700,000
1,879,100,000
1,947,700,000
2,054,100,000
2,016,200,000
1,968,600,000
1,882,400,000
1,773,400,000
1,457,401,000
1,127,064,000
804,734,000
528,399,000
475,786,000
466,224,000
435,363,000
403,569,000
364,297,000
334,735,000
325,737,000
319,482,000
319,105,000
299,510,000
285,939,000
276,655,000
259,634,000
263,895,000
245,357,000
243,578,000
233,919,000
232,064,000
250,414,000
265,425,000
266,379,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.